宋 丹, 史 茜, 侯向前. The effect of mutations in the upstream regulatory region of HPV-16 on the activity of virus early promoter[J]. China Oncology, 2017, 27(2): 109-114.
宋 丹, 史 茜, 侯向前. The effect of mutations in the upstream regulatory region of HPV-16 on the activity of virus early promoter[J]. China Oncology, 2017, 27(2): 109-114. DOI: 10.19401/j.cnki.1007-3639.2017.02.005.
Background and purpose: The incidence of cervical cancer is rather high in Xinjiang
which is closely associated with the infection of human papilloma virus type 16 (HPV-16). The purpose of this study was to analyze the variants and function of HPV-16 upstream regulatory region (URR) in the tissues of cervical cancer biopsies from Xinjiang. Methods: The DNAs were extracted from the tissues of cervical epithelial atypical hyperplasia (CIN) and cervical cancer biopsies. HPV-16 URR segments were amplified by PCR. Based on the sequence analysis of the URR
the representative URR variants were selected and cloned into pGL3-Basic. The recombinant plasmids were transfected into Vero cell lines respetively. Luciferase activity of transfected cells was detected 48 h after transfection. Results: Fifty-five HPV-16 URR DNA fragments were obtained through PCR
and 44 mutations were found from the URR fragments. 4 of these mutations
including nt7192(G→T)
nt7433(- →T)
nt7435 (C→G) and nt7863 (A→-) occurred in all sequences. The mutation at nt7520 (G→A) occurred in 54 URR sequences
and the 39 other mutations were present in different samples. Based on the location and frequency of the mutations in the URR fragments
9 URR variants were selected and cloned into pGL3-Basic. Then the luciferase activity of the cells transfected with pGL3- URR plasmids was detected respectively. Promoter activity of URR mutants from cervical cancer are significantly higher than that of URR mutants from CIN (P0.01). Promoter activity of URR fragments from some cervical cancer was significantly higher than that of the URR fragments from SiHa and Caski cells. Conclusion: Multiple mutations occurred in HPV-16 URR of cervical cancer patients from Xinjiang. The promoter activity and carcinogenicity of some URR mutants have been enhanced.